The College of Graduate Studies’ Master of Science in Biomedical Sciences and Master of Science in Pharmaceutical Sciences programs were created to address the needs of rapidly growing bioscience industries across the Intermountain West.

Utah has seen the fastest growth in biopharmaceutical and medical device employment in the country with more than 1,000 life sciences companies, $10 billion in annual sales and employing nearly 35,000 employees, and a projected increase of nearly 1,000 positions in the coming years.

Nevada’s growth in the biotech sector has also been robust, with more than 900 bioscience companies attracting nearly $90 million in venture capital.  Training qualified scientists to meet this growing demand is critical for continued economic development and diversification in the region.

Industry partners confirm that demand is high for graduates of research-focused master’s programs. Joseph F. Nowoslawski, MD, CEO of JSK Therapeutics in Sandy, Utah contributed to the development of the College’s programs. He said, “This is a great solution to helping build the biotech infrastructure in the region and an excellent tool for professionals who want a career in helping research startups blossom and create new breakthroughs.  With this background, graduates will be in great demand in the biotech sector. I highly recommend this training.”

Vance Farrow, healthcare industry specialist from the Nevada Governor’s Office of Economic Development underscored the value of Roseman’s industry partnerships. He added, “From what we have all witnessed over the past year, the need for graduates from Roseman’s master of science programs will only increase as industry research and development continues to reach further into the biomedical and pharmaceutical sciences to solve our world’s critical health problems. Partnering with leading industry stakeholders is a brilliant way to prepare our students, while exposing them to potential employers and rewarding careers to further diversify our state’s economy.”